In a surprising turn of events, the Chargers almost closed the gap but the Texans' special teams had other plans. Quarterback Justin Herbert managed to toss an 86-yard touchdown pass to Ladd McConkey, despite facing a critical third-and-26. McConkey's catch and run saw him escaping several tackles a
Bong Joon-ho's new sci-fi movie, "Mickey 17, " will hit South Korean screens on February 28. This is a week before its global release. The movie is based on Edward Ashton's 2022 novel "Mickey7. " Robert Pattinson stars as Mickey Barnes, an "expendable" employee on dangerous missions to colonize an i
Val Boreland, a top executive known for scoring big content deals for NBCUniversal's cable networks, has been tapped to lead the entertainment division of a new spin-off company. This new entity, dubbed "SpinCo, " will be a separate, publicly traded part of NBCUniversal and is expected to launch lat
Treatment options for epithelial ovarian cancer (EOC) have expanded a lot in recent years, but much of the progress has been tied to picking the right biomarkers. This means there's still a big need for better treatment options to help patients live longer and enjoy better quality of life. Unlike ma
Ever thought why some days stand out? Well, January 9, 2025, is one of those days. This day is dedicated to remembering the 39th U. S. President, James Earl Carter Jr. President Biden has declared it a National Day of Mourning. So, if you've got a naturalization ceremony, interview, or appointment p
Point-of-care ultrasound (POCUS) is a real game-changer in medicine. It's used in lots of specialties to help doctors make better decisions and care for patients. Many medical schools are now including POCUS in their programs. Some start early, others spread it out over the whole four years. Midwest
You might not think about it, but the time of day you get your cancer treatment could make a difference. Scientists have been looking into how our body's internal clock, called the circadian rhythm, affects how well cancer drugs work. One type of drug, called immune checkpoint inhibitors (ICIs), has
Biliary tract cancers, like cholangiocarcinoma and gallbladder cancer, are growing more common worldwide, and most patients get diagnosed when the disease has already advanced, leading to a grim outlook. Recently, combining immune checkpoint inhibitors, such as durvalumab and pembrolizumab, with the
Immune-checkpoint inhibitors (ICIs) have emerged as a powerful tool in the fight against advanced squamous cell lung cancer (LUSC). These drugs offer a glimmer of hope for patients who haven't found success with other treatments. But it's not a one-size-fits-all solution—some patients don't respond
Get ready for something truly unique! Rapper and professor Lupe Fiasco is set to launch Endless LUP, an AI-powered radio station in 2025. This isn't your usual radio station; it's designed to play AI-generated versions of Lupe's music. He shared the exciting news on Instagram, explaining that the st
